Skip to main content
Drug bottle and Pill

Compare Victoza vs. Byetta

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Victoza (liraglutide) and exenatide (Byetta, Bydureon BCise) are both injectable medications used to manage Type 2 diabetes, but they have some key differences. Victoza is administered once daily with or without food, while exenatide is administered twice daily before meals. Exenatide is also available as a long-acting option (Bydureon BCise), which is administered once a week. Victoza and long-acting exenatide (Bydureon BCise) are approved for use in people aged 10 and older, whereas short-acting exenatide (Byetta) is only for adults. Additionally, Victoza has the added benefit of lowering the risk of major heart-related problems in adults with Type 2 diabetes and heart disease. Both medications can help with weight loss, but neither is FDA-approved specifically for this purpose. Victoza and exenatide can cause similar side effects like nausea and vomiting, but exenatide has a higher rate of these side effects, particularly for nausea. Additionally, both medications carry risks of thyroid cancer and inflammation of the pancreas, but exenatide also has a risk of severe bleeding.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.